Nexavar in Patients with Renal Cell Carcinoma
Dyslipidemia and Cardiovascular Risk Reduction: An Evidence-Based Review Robert M. Guthrie, MD Professor of Emergency Medicine Professor of Internal Medicine.
The Effects of Early Ambulation Post-Hip Arthroplasty
Personalized therapy in Pediatric ALL: Allen Yeoh
A Low-Cost Framework for Individualized Interactive Telerehabilitation Chetan Jadhav Advisor: Dr. Venkat Krovi Mechanical and Aerospace Engineering Department.
Statins and CAD Prevention: Rosuvastatin. Rising burden of CVD in India (2005) Lancet 2005;366:1744-9 Estimated proportions of total deaths and DALYs.
NIV in the ICU: Lessons learnt in the last 20 years
Dyslipidemia and Cardiovascular Risk Reduction: An Evidence-Based Review MacRae F. Linton, MD Professor of Medicine and Pharmacology Division of Cardiovascular.
Dyslipidemia and Cardiovascular Risk Reduction: An Evidence-Based Review Latha Palaniappan, MD, MS Adjunct Clinical Assistant Professor Department of Internal.
Is intensity of therapy important? Dr Derick T Wade, Professor in Neurological Rehabilitation, Oxford Centre for Enablement, Windmill Road, OXFORD OX3.
Is intensity of therapy important?
